Vanda Pharmaceuticals to Present at the Deutsche Bank 42nd Annual Health Care Conference

WASHINGTON, May 1, 2017 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced that it will deliver a corporate presentation at the Deutsche Bank 42^nd Annual Health Care Conference in Boston, Massachusetts on Thursday, May 4, 2017 at 8:40 a.m. Eastern Time.

The presentation at the Deutsche Bank Health Care Conference will be available live on Vanda's corporate website, where it also will be archived for 30 days. To access the presentation, go to Vanda's website at www.vandapharma.com and click on the Presentations tab on the Investor Relations page.  Please connect to the website several minutes prior to the start of the live presentation.

About Vanda Pharmaceuticals Inc.

Vanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda, please visit www.vandapharma.com.

Company Contact:
Jim Kelly
Executive Vice President and Chief Financial Officer
Vanda Pharmaceuticals Inc.
(202) 734-3428
jim.kelly@vandapharma.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-to-present-at-the-deutsche-bank-42nd-annual-health-care-conference-300449060.html

SOURCE Vanda Pharmaceuticals Inc.